These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 10732934

  • 1. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ.
    JAMA; 2000 Mar 15; 283(11):1445-50. PubMed ID: 10732934
    [Abstract] [Full Text] [Related]

  • 2. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
    Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC, Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators.
    Ann Intern Med; 2002 Oct 15; 137(8):640-7. PubMed ID: 12379063
    [Abstract] [Full Text] [Related]

  • 3. Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.
    Rose DN.
    Ann Intern Med; 1998 Nov 15; 129(10):779-86. PubMed ID: 9841583
    [Abstract] [Full Text] [Related]

  • 4. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
    Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ.
    N Engl J Med; 1997 Sep 18; 337(12):801-8. PubMed ID: 9295239
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, Padmapriyadarsini C, Ramachandran R, Chinnaiyan P, Suhadev M, Sakthivel R, Narayanan PR.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):743-51. PubMed ID: 19965813
    [Abstract] [Full Text] [Related]

  • 6. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP.
    Int J Tuberc Lung Dis; 2006 Oct 01; 10(10):1080-90. PubMed ID: 17044199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
    Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KP, Porter JD.
    AIDS; 1998 Dec 24; 12(18):2447-57. PubMed ID: 9875583
    [Abstract] [Full Text] [Related]

  • 11. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov 24; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    García-Rodríguez JF, Valcarce-Pardeiro N, Álvarez-Díaz H, Mariño-Callejo A.
    Eur J Clin Microbiol Infect Dis; 2019 Nov 24; 38(11):2121-2126. PubMed ID: 31377953
    [Abstract] [Full Text] [Related]

  • 13. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
    Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE.
    Am J Respir Crit Care Med; 2006 Apr 15; 173(8):922-6. PubMed ID: 16474028
    [Abstract] [Full Text] [Related]

  • 14. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
    Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, International Maternal Pediatric and Adolescents AIDS Clinical Trials Group, Tuberculosis Trials Consortium.
    JAMA Pediatr; 2015 Mar 15; 169(3):247-55. PubMed ID: 25580725
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group].
    Martínez Alfaro EM, Cuadra F, Solera J, Maciá MA, Geijo P, Sánchez Martínez PA, Rodríguez Zapata M, Largo J, Sepúlveda MA, Rosa C, Sánchez L, Espinosa A, Mateos F, Blanch JJ.
    Med Clin (Barc); 2000 Jul 01; 115(5):161-5. PubMed ID: 10996870
    [Abstract] [Full Text] [Related]

  • 16. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
    McNeill L, Allen M, Estrada C, Cook P.
    Chest; 2003 Jan 01; 123(1):102-6. PubMed ID: 12527609
    [Abstract] [Full Text] [Related]

  • 17. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R, Heilig CM, Tapy JM, Bozeman L, Kyle RP, Hamilton CD, Bock N, Narita M, Wing D, Hershfield E, Goldberg SV, Tuberculosis Trials Consortium.
    Int J Tuberc Lung Dis; 2014 May 01; 18(5):571-80. PubMed ID: 24903795
    [Abstract] [Full Text] [Related]

  • 18. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep 01; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG).
    el-Sadr WM, Perlman DC, Matts JP, Nelson ET, Cohn DL, Salomon N, Olibrice M, Medard F, Chirgwin KD, Mildvan D, Jones BE, Telzak EE, Klein O, Heifets L, Hafner R.
    Clin Infect Dis; 1998 May 01; 26(5):1148-58. PubMed ID: 9597244
    [Abstract] [Full Text] [Related]

  • 20. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A, Burman W, Benator D, Khan A, Bozeman L.
    Lancet; 1999 May 29; 353(9167):1843-7. PubMed ID: 10359410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.